Hyperglycaemia, inflammation and early cardiac remodelling in non-surgically revascularized STEMI: the role of microvascular obstruction and intramyocardial haemorrhage.

IF 0.6 Q4 CARDIAC & CARDIOVASCULAR SYSTEMS
Vyacheslav Ryabov, Evgeny Vyshlov, Stanislav Dil, Yana Alexeeva, Vladimir Usov, Olga Mochula, Konstantin Zavadovsky, Kristina Nasekina, Leonid Maslov
{"title":"Hyperglycaemia, inflammation and early cardiac remodelling in non-surgically revascularized STEMI: the role of microvascular obstruction and intramyocardial haemorrhage.","authors":"Vyacheslav Ryabov, Evgeny Vyshlov, Stanislav Dil, Yana Alexeeva, Vladimir Usov, Olga Mochula, Konstantin Zavadovsky, Kristina Nasekina, Leonid Maslov","doi":"10.1007/s12055-025-02082-8","DOIUrl":null,"url":null,"abstract":"<p><strong>Background and aims: </strong>In ST-elevation myocardial infarction (STEMI), timely reperfusion via percutaneous coronary intervention (PCI) reduces mortality but is limited by microvascular injury (MVI), including microvascular obstruction (MVO) and intramyocardial hemorrhage (IMH), which drive adverse cardiac remodeling. This study evaluates the incidence of MVO and IMH, their combined effects, and associations with hyperglycemia, inflammation, and left ventricular (LV) dysfunction after successful non-surgical revascularization of STEMI.</p><p><strong>Methods and results: </strong>A single-center cohort of 60 STEMI patients (2019-2020) underwent contrast-enhanced cardiac magnetic resonance imaging (MRI) 48 ± 6 h post-infarction to assess MVI. Patients were classified into four groups: no MVI, isolated MVO, isolated IMH, and combined MVO + IMH. For some analyses, patients were also dichotomized into MVI-present versus MVI-absent groups to facilitate comparison of functional and biochemical outcomes. LV function was evaluated via echocardiography (days 7 and 90). Biomarkers were analyzed at admission and day 7. MVI occurred in 68.3% of patients: isolated MVO (16.7%), isolated IMH (15%), and combined MVO + IMH (36.7%). Combined MVO + IMH correlated with larger infarct size, prolonged ischemia, and higher admission glucose. C-reactive protein (CRP) levels on day 7 were elevated in isolated MVO (59.8 [9.1-75.9] mg/L) and MVO + IMH (32.8 [4-55.6] mg/L) versus no-MVI (4.6 [2.9-12.7] mg/L). LV ejection fraction (LVEF) was significantly lower in MVO + IMH groups (p < 0.05). Admission glucose inversely correlated with day 7 LVEF (r = -0.43, p < 0.0001).</p><p><strong>Conclusion: </strong>Combined MVO and IMH was associated with a more unfavorable remodeling pattern and subtle LV dysfunction, which may be exaggerated by hyperglycemia and inflammation. Elevated CRP links MVO to systemic inflammation, while IMH reflects mechanical capillary damage. These findings emphasize the need for early glycemic control, anti-inflammatory strategies, and imaging-guided risk stratification to mitigate microvascular injury and improve outcomes in STEMI.</p><p><strong>Graphical abstract: </strong>AMI-Acute Myocardial Infarction; IMH-Intramyocardial Hemorrhage: MVO-Microvascular Obstruction.Hyperglycaemia, inflammation and early cardiac remodelling in non-surgically revascularized STEMI: the role of microvascular obstruction and intramyocardial haemorrhage.</p><p><strong>Supplementary information: </strong>The online version contains supplementary material available at 10.1007/s12055-025-02082-8.</p>","PeriodicalId":13285,"journal":{"name":"Indian Journal of Thoracic and Cardiovascular Surgery","volume":"42 5","pages":"595-607"},"PeriodicalIF":0.6000,"publicationDate":"2026-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13065921/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Indian Journal of Thoracic and Cardiovascular Surgery","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1007/s12055-025-02082-8","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/12/17 0:00:00","PubModel":"Epub","JCR":"Q4","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0

Abstract

Background and aims: In ST-elevation myocardial infarction (STEMI), timely reperfusion via percutaneous coronary intervention (PCI) reduces mortality but is limited by microvascular injury (MVI), including microvascular obstruction (MVO) and intramyocardial hemorrhage (IMH), which drive adverse cardiac remodeling. This study evaluates the incidence of MVO and IMH, their combined effects, and associations with hyperglycemia, inflammation, and left ventricular (LV) dysfunction after successful non-surgical revascularization of STEMI.

Methods and results: A single-center cohort of 60 STEMI patients (2019-2020) underwent contrast-enhanced cardiac magnetic resonance imaging (MRI) 48 ± 6 h post-infarction to assess MVI. Patients were classified into four groups: no MVI, isolated MVO, isolated IMH, and combined MVO + IMH. For some analyses, patients were also dichotomized into MVI-present versus MVI-absent groups to facilitate comparison of functional and biochemical outcomes. LV function was evaluated via echocardiography (days 7 and 90). Biomarkers were analyzed at admission and day 7. MVI occurred in 68.3% of patients: isolated MVO (16.7%), isolated IMH (15%), and combined MVO + IMH (36.7%). Combined MVO + IMH correlated with larger infarct size, prolonged ischemia, and higher admission glucose. C-reactive protein (CRP) levels on day 7 were elevated in isolated MVO (59.8 [9.1-75.9] mg/L) and MVO + IMH (32.8 [4-55.6] mg/L) versus no-MVI (4.6 [2.9-12.7] mg/L). LV ejection fraction (LVEF) was significantly lower in MVO + IMH groups (p < 0.05). Admission glucose inversely correlated with day 7 LVEF (r = -0.43, p < 0.0001).

Conclusion: Combined MVO and IMH was associated with a more unfavorable remodeling pattern and subtle LV dysfunction, which may be exaggerated by hyperglycemia and inflammation. Elevated CRP links MVO to systemic inflammation, while IMH reflects mechanical capillary damage. These findings emphasize the need for early glycemic control, anti-inflammatory strategies, and imaging-guided risk stratification to mitigate microvascular injury and improve outcomes in STEMI.

Graphical abstract: AMI-Acute Myocardial Infarction; IMH-Intramyocardial Hemorrhage: MVO-Microvascular Obstruction.Hyperglycaemia, inflammation and early cardiac remodelling in non-surgically revascularized STEMI: the role of microvascular obstruction and intramyocardial haemorrhage.

Supplementary information: The online version contains supplementary material available at 10.1007/s12055-025-02082-8.

高血糖,炎症和早期心脏重构在非手术重建STEMI:微血管阻塞和心内出血的作用。
背景和目的:在st段抬高型心肌梗死(STEMI)中,通过经皮冠状动脉介入治疗(PCI)及时再灌注可降低死亡率,但受微血管损伤(MVI)的限制,包括微血管阻塞(MVO)和心肌内出血(IMH),这些损伤会导致不良的心脏重构。本研究评估STEMI非手术血运重建术成功后MVO和IMH的发生率、它们的联合效应以及与高血糖、炎症和左心室功能障碍的关系。方法和结果:对60例STEMI患者(2019-2020)进行单中心队列研究,在梗死后48±6小时进行心脏磁共振造影(MRI)评估MVI。将患者分为4组:无MVI、分离性MVO、分离性IMH和MVO + IMH合并。在一些分析中,患者也被分为mvi存在组和mvi不存在组,以便于比较功能和生化结果。通过超声心动图评估左室功能(第7天和第90天)。在入院和第7天分析生物标志物。MVI发生在68.3%的患者中:分离性MVO(16.7%)、分离性IMH(15%)和MVO + IMH联合(36.7%)。合并MVO + IMH与梗死面积增大、缺血时间延长和入院血糖升高相关。与无mvi组(4.6 [2.9-12.7]mg/L)相比,MVO组第7天c反应蛋白(CRP)水平升高(59.8 [9.1-75.9]mg/L)和MVO + IMH组(32.8 [4-55.6]mg/L)。结论:MVO + IMH组左室射血分数(LVEF)明显降低(p)。结论:MVO + IMH组左室重构模式更不利,左室功能障碍更轻微,且可能因高血糖和炎症而加重。CRP升高将MVO与全身性炎症联系起来,而IMH则反映机械性毛细血管损伤。这些发现强调了早期血糖控制、抗炎策略和成像引导的风险分层的必要性,以减轻STEMI的微血管损伤并改善预后。图形摘要:ami -急性心肌梗死;imh -心内出血:mvo -微血管阻塞。高血糖,炎症和早期心脏重构在非手术重建STEMI:微血管阻塞和心内出血的作用。补充信息:在线版本包含补充资料,可在10.1007/s12055-025-02082-8获得。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Indian Journal of Thoracic and Cardiovascular Surgery
Indian Journal of Thoracic and Cardiovascular Surgery CARDIAC & CARDIOVASCULAR SYSTEMS-
CiteScore
1.20
自引率
14.30%
发文量
141
期刊介绍: The primary aim of the Indian Journal of Thoracic and Cardiovascular Surgery is education. The journal aims to dissipate current clinical practices and developments in the area of cardiovascular and thoracic surgery. This includes information on cardiovascular epidemiology, aetiopathogenesis, clinical manifestation etc. The journal accepts manuscripts from cardiovascular anaesthesia, cardiothoracic and vascular nursing and technology development and new/innovative products.The journal is the official publication of the Indian Association of Cardiovascular and Thoracic Surgeons which has a membership of over 1000 at present.DescriptionThe journal is the official organ of the Indian Association of Cardiovascular-Thoracic Surgeons. It was started in 1982 by Dr. Solomon Victor and ws being published twice a year up to 1996. From 2000 the editorial office moved to Delhi. From 2001 the journal was extended to quarterly and subsequently four issues annually have been printed out at time and regularly without fail. The journal receives manuscripts from members and non-members and cardiovascular surgeons. The manuscripts are peer reviewed by at least two or sometimes three or four reviewers who are on the panel. The manuscript process is now completely online. Funding the journal comes partially from the organization and from revenue generated by subscription and advertisement.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书